Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers

 

 Buy Article Permissions and Reprints

Abstract

Clarithromycin (CM), a broad spectrum macrolide antibiotic used to eradicate H. pylori in peptic ulcer. Clarithromycin (CM) is well absorbed from the gastrointestinal tract, but has a bioavailability of 50% due to rapid biodegradation. The aim of this investigation was to increase the gastric residence time, and to control the drug release of clarithromycin by formulating into multiple unit floating mini-tablets. Floating tablets were prepared by using direct compression method with HPMC K₄M and Polyox WSR 1105 as release retarded polymers and sodium bicarbonate as gas generating agent. The prepared mini-tablets were evaluated for thickness, weight variation, friability, hardness, drug content, in vitro buoyancy, swelling studies, in vitro dissolution studies by using modified Rossett-Rice test and in vivo radiographic studies in healthy human volunteers in fasting conditions. DSC analysis revealed that no interaction between drug and excipients. All the physical parameters of the tablets were within the acceptable limits. The optimized formulation (F6) had showed controlled drug release of 99.16±3.22% in 12 h, by zero-order release kinetics, along with floating lag time of 9.5±1.28 s and total floating time of 12±0.14 h. X-ray imaging studies revealed that in vivo gastric residence time of clarithromycin floating mini-tablet in the stomach was about 3.5 h. The results demonstrated that the developed floating mini-tablets of clarithromycin caused significant enhancement in gastric retention time along with sustained effect and increased oral bioavailability.

• References

• 1 Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994; 343: 243-244
  CrossrefPubMedGoogle Scholar
• 2 Vyas SP, Khar RK. Gastro retentive systems. In: Controlled drug Delivery. Delhi, India: Vallabh Prakashan; 2006: 197-217
  Google Scholar
• 3 Brazel CS, Peppas NA. Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 2000; 49: 47-58
  CrossrefPubMedGoogle Scholar
• 4 Bardonn PL, Faivre V, Pugh WJ. et al. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J Contr Rel 2006; 111: 1-18
  CrossrefPubMedGoogle Scholar
• 5 Bomma R, Naidu RAS, Rao YM. et al. Development and evaluation of gastro retentive norfloxacin floating tablets. Acta Pharm 2009; 59: 211-221
  CrossrefPubMedGoogle Scholar
• 6 Bandari S, Eaga CM, Thadishetty A. et al. Formulation and evaluation of multiple tablets as a biphasic gastro retentive floating drug delivery system for fenoverine. Acta Pharm 2010; 60: 89-97
  CrossrefPubMedGoogle Scholar
• 7 Bechgaard H, Neilson GH. Controlled release multiple units and single-unit doses. Drug Dev Ind Pharm 1978; 4: 53-67
  CrossrefPubMedGoogle Scholar
• 8 Vivek KP, Shalini A, Mishra N. et al. Chitosan coated hydroxy propyl methyl cellulose ethyl cellulose shell based gastro retentive dual working system to improve the bioavailability of norfloxacin. RSC Advances 2013; 10: 19144-19153
  PubMedGoogle Scholar
• 9 Lingam M, Ashok T, Venkateswarlu V. et al. Design and evaluation of a novel matrix type multiple units as biphasic gastro retentive drug delivery systems. AAPS Pharm SciTech 2008; 9: 1253-1261
  PubMedGoogle Scholar
• 10 Chambers HF. Antimicrobial agents. In Goodman & Gilman’s. The Pharmacological Basis of Therapeutics. 10th edition Hardman JG, Limbird JE. Eds. New York: McGraw-Hill Medical Publishing Div; 2001: 1250-1256
  Google Scholar
• 11 Sunil KJ, Manmohan SJ. Lectin conjugated gastro retentive multi particulate delivery system of clarithromycin for the effective treatment of helicobacter pylori. Mol Pharma 2009; 6: 295-304
  CrossrefPubMedGoogle Scholar
• 12 Sally AEZ, Abeer A. Kassem et al. Design and evaluation of gastro retentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori. Saudi Pharm J 2014; 22: 570-579
  CrossrefPubMedGoogle Scholar
• 13 Desai S, Bolton S. A floating controlled release drug delivery system. In vitro and in vivo evaluation. Pharm Res 1993; 10: 1321-1325
  CrossrefPubMedGoogle Scholar
• 14 Burns SJ, Attwood D, Barnwell SG. Assessment of a dissolution vessel designed for use with floating and erodible dosage forms. Int J Pharm 1998; 160: 213-218
  CrossrefPubMedGoogle Scholar
• 15 Hadi MA, Babu VL, Pal N. Formulation and evaluation of sustained release matrix tablets of glimepiride based on combination of hydrophilic and hydrophobic polymers. J Appl Pharm Sci 2012; 2: 101-107
  PubMedGoogle Scholar
• 16 Rosa M, Zia H, Rhodes T. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 1994; 105: 65-70
  CrossrefPubMedGoogle Scholar
• 17 Splvey RJ, Goodhart FW. In vitro acid reactivity of three commercial antacid tablets. Am J Hosp Pharm 1979; 36: 660-663
  PubMedGoogle Scholar
• 18 Mukesh CG, Pavak RM, Rikita KD et al. A more relevant dissolution method for evaluation of floating drug delivery system. Diso Tech 2004
  PubMed
• 19 Costa P, Sousa Lobo JM. Modelling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13: 123-133
  CrossrefPubMedGoogle Scholar
• 20 Korsmeyer RW, Gurny R, Doelker E. et al. Mechanism of solute release from porous hydro-matrices and other factors may be responsible. Int J Pharm 1983; 15: 25-35
  CrossrefPubMedGoogle Scholar
• 21 Peppas NA. Analysis of Fickian and non-Fickian drug matrix tablets with respect to the compression force release from polymers. Pharm Acta Hel 1985; 60: 110-111
  PubMedGoogle Scholar
• 22 Dorozynski P, Jachowicz R, Kulinowski P. et al. The polymers for the preparation of hydrodynamically balanced systems – methods of evaluation. Drug Dev Ind Pharm 2004; 30: 947-957
  CrossrefPubMedGoogle Scholar
• 23 Narendar D, Chinna Reddy P, Sunil R. et al. Development of floating matrix tablets of ofloxacin and ornidazole in combined dosage form: in vitro and in vivo evaluation in healthy human volunteers. Int J. Drug Deliv 2012; 4: 462-469
  PubMedGoogle Scholar
• 24 Wilson B, Sitarambhai PH, Sajeev M. et al. Design and evaluation of sustained release matrix tablets of levofloxacin for effective treatment of microbial infections. Int J. Drug Deliv 2011; 3: 305-314
  PubMedGoogle Scholar
• 25 Doodipala N, Palem RC, Reddy S. et al. Pharmaceutical development and clinical pharmacokinetic evaluation of gastro retentive floating matrix tablets of levofloxacin. Int J Pharm Sci Nanotech 2011; 4: 1463-1469
  PubMedGoogle Scholar
• 26 Mamoru F, Nicholas A, James W. Floating hot-melt extruded tablets for gastro retentive controlled drug release system. J Contr Rel 2006; 115: 121-129
  CrossrefPubMedGoogle Scholar